|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||0.10 / 0.19|
AtheroGenics was up and Affymetrix was down in an uneven market for health care stocks.
Harbin Electric, ImClone, CPI and Bowne & Co. upgraded; RF Industries and General Communication downgraded.
John Bollinger says the market looks good as earnings season starts amid more drama in housing, biotech and M&A.
John Bollinger says the market is strong as Alcoa kicks off earnings season. Plus, drama in housing, biotech and M&A moves stocks.
A Swiss drug company's acquisition of BioVeris vaulted the company's stock.
Sales potential for Vectibix will be an important tell in its report.
The Nasdaq jumps despite worries about the economy, the Fed, commodities and the rally's age.
Action in energy and biotech stocks might suggest a slowing economy, but not with a raging tech sector.
The biotech is making progress with its drug for hepatitis C.
It improves survival in one phase III trial but not in another.
Skilling's sentencing is the end of corporate scandals ... umm, maybe not. Plus, don't cross Jobs.
The business media fail to note that corporate raider Carl Icahn lacks more than just scientific expertise.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.